Bone associated with implants in diabetic and insulin-treated rats

Michael S. McCracken, Ruth Aponte-Wesson, Ramakiran Chavali, Jack E. Lemons

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objectives: Diabetes is an increasingly prevalent disease with oral health manifestations. While diabetes clearly has an affect on bone, its impact on the healing of bone associated with dental implants is not completely understood. The purpose of this study was to measure bone response to implants in uncontrolled and insulin-controlled diabetic rats. Material and methods: One hundred and fifty-two rats were divided into control, diabetic, and insulin groups. Rats received streptozotocin (65 mg/kg) to induce diabetes; animals in the insulin group also received a subcutaneous slow-release insulin implant. Titanium alloy implants (1.5 × 8 mm) were placed in the proximal tibiae of animals. Implants were harvested at 2, 7, 14, and 24 days and examined histologically. Bone or bone-like tissue adjacent to implants was quantified as a percent. Data were compared using a two-way analysis is variance (ANOVA) with time and treatment as primary independent factors. Results: Time and treatment were significant factors in predicting bone response to implants (P<0.0001). Mean bone volume peaked at day 7 and decreased over time to day 24. Mean bone volume percent at 2, 7, 14, and 24 days (±SD) was 8.2 (±8), 22.9 (±8), 18.8 (±10), and 14.9 (±9), respectively. Mean total bone volume percent (adjusted for day) for control, diabetic, and insulin groups (±SD) was 12.4 (±9), 22.6 (±10), and 17 (±7), respectively. Bone volume adjacent to implants in diabetic rats was significantly greater than controls (P<0.05). Diabetic animals treated with insulin were not statistically different from controls. Conclusions: Induction of diabetes with STZ is associated with increased bone response compared with controls. This response was mediated by treatment with insulin.

Original languageEnglish (US)
Pages (from-to)495-500
Number of pages6
JournalClinical Oral Implants Research
Volume17
Issue number5
DOIs
StatePublished - Oct 1 2006

Fingerprint

Insulin
Bone and Bones
Analysis of Variance
Oral Manifestations
Dental Implants
Oral Health
Streptozocin
Titanium
Tibia

Keywords

  • Animal study
  • Dental implants
  • Diabetes
  • Insulin
  • Rats
  • Streptozotocin

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Bone associated with implants in diabetic and insulin-treated rats. / McCracken, Michael S.; Aponte-Wesson, Ruth; Chavali, Ramakiran; Lemons, Jack E.

In: Clinical Oral Implants Research, Vol. 17, No. 5, 01.10.2006, p. 495-500.

Research output: Contribution to journalArticle

McCracken, MS, Aponte-Wesson, R, Chavali, R & Lemons, JE 2006, 'Bone associated with implants in diabetic and insulin-treated rats', Clinical Oral Implants Research, vol. 17, no. 5, pp. 495-500. https://doi.org/10.1111/j.1600-0501.2006.01266.x
McCracken, Michael S. ; Aponte-Wesson, Ruth ; Chavali, Ramakiran ; Lemons, Jack E. / Bone associated with implants in diabetic and insulin-treated rats. In: Clinical Oral Implants Research. 2006 ; Vol. 17, No. 5. pp. 495-500.
@article{0f4ac5bfaa704cf6a9498fd054cb7e9f,
title = "Bone associated with implants in diabetic and insulin-treated rats",
abstract = "Objectives: Diabetes is an increasingly prevalent disease with oral health manifestations. While diabetes clearly has an affect on bone, its impact on the healing of bone associated with dental implants is not completely understood. The purpose of this study was to measure bone response to implants in uncontrolled and insulin-controlled diabetic rats. Material and methods: One hundred and fifty-two rats were divided into control, diabetic, and insulin groups. Rats received streptozotocin (65 mg/kg) to induce diabetes; animals in the insulin group also received a subcutaneous slow-release insulin implant. Titanium alloy implants (1.5 × 8 mm) were placed in the proximal tibiae of animals. Implants were harvested at 2, 7, 14, and 24 days and examined histologically. Bone or bone-like tissue adjacent to implants was quantified as a percent. Data were compared using a two-way analysis is variance (ANOVA) with time and treatment as primary independent factors. Results: Time and treatment were significant factors in predicting bone response to implants (P<0.0001). Mean bone volume peaked at day 7 and decreased over time to day 24. Mean bone volume percent at 2, 7, 14, and 24 days (±SD) was 8.2 (±8), 22.9 (±8), 18.8 (±10), and 14.9 (±9), respectively. Mean total bone volume percent (adjusted for day) for control, diabetic, and insulin groups (±SD) was 12.4 (±9), 22.6 (±10), and 17 (±7), respectively. Bone volume adjacent to implants in diabetic rats was significantly greater than controls (P<0.05). Diabetic animals treated with insulin were not statistically different from controls. Conclusions: Induction of diabetes with STZ is associated with increased bone response compared with controls. This response was mediated by treatment with insulin.",
keywords = "Animal study, Dental implants, Diabetes, Insulin, Rats, Streptozotocin",
author = "McCracken, {Michael S.} and Ruth Aponte-Wesson and Ramakiran Chavali and Lemons, {Jack E.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1111/j.1600-0501.2006.01266.x",
language = "English (US)",
volume = "17",
pages = "495--500",
journal = "Clinical Oral Implants Research",
issn = "0905-7161",
publisher = "Blackwell Munksgaard",
number = "5",

}

TY - JOUR

T1 - Bone associated with implants in diabetic and insulin-treated rats

AU - McCracken, Michael S.

AU - Aponte-Wesson, Ruth

AU - Chavali, Ramakiran

AU - Lemons, Jack E.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Objectives: Diabetes is an increasingly prevalent disease with oral health manifestations. While diabetes clearly has an affect on bone, its impact on the healing of bone associated with dental implants is not completely understood. The purpose of this study was to measure bone response to implants in uncontrolled and insulin-controlled diabetic rats. Material and methods: One hundred and fifty-two rats were divided into control, diabetic, and insulin groups. Rats received streptozotocin (65 mg/kg) to induce diabetes; animals in the insulin group also received a subcutaneous slow-release insulin implant. Titanium alloy implants (1.5 × 8 mm) were placed in the proximal tibiae of animals. Implants were harvested at 2, 7, 14, and 24 days and examined histologically. Bone or bone-like tissue adjacent to implants was quantified as a percent. Data were compared using a two-way analysis is variance (ANOVA) with time and treatment as primary independent factors. Results: Time and treatment were significant factors in predicting bone response to implants (P<0.0001). Mean bone volume peaked at day 7 and decreased over time to day 24. Mean bone volume percent at 2, 7, 14, and 24 days (±SD) was 8.2 (±8), 22.9 (±8), 18.8 (±10), and 14.9 (±9), respectively. Mean total bone volume percent (adjusted for day) for control, diabetic, and insulin groups (±SD) was 12.4 (±9), 22.6 (±10), and 17 (±7), respectively. Bone volume adjacent to implants in diabetic rats was significantly greater than controls (P<0.05). Diabetic animals treated with insulin were not statistically different from controls. Conclusions: Induction of diabetes with STZ is associated with increased bone response compared with controls. This response was mediated by treatment with insulin.

AB - Objectives: Diabetes is an increasingly prevalent disease with oral health manifestations. While diabetes clearly has an affect on bone, its impact on the healing of bone associated with dental implants is not completely understood. The purpose of this study was to measure bone response to implants in uncontrolled and insulin-controlled diabetic rats. Material and methods: One hundred and fifty-two rats were divided into control, diabetic, and insulin groups. Rats received streptozotocin (65 mg/kg) to induce diabetes; animals in the insulin group also received a subcutaneous slow-release insulin implant. Titanium alloy implants (1.5 × 8 mm) were placed in the proximal tibiae of animals. Implants were harvested at 2, 7, 14, and 24 days and examined histologically. Bone or bone-like tissue adjacent to implants was quantified as a percent. Data were compared using a two-way analysis is variance (ANOVA) with time and treatment as primary independent factors. Results: Time and treatment were significant factors in predicting bone response to implants (P<0.0001). Mean bone volume peaked at day 7 and decreased over time to day 24. Mean bone volume percent at 2, 7, 14, and 24 days (±SD) was 8.2 (±8), 22.9 (±8), 18.8 (±10), and 14.9 (±9), respectively. Mean total bone volume percent (adjusted for day) for control, diabetic, and insulin groups (±SD) was 12.4 (±9), 22.6 (±10), and 17 (±7), respectively. Bone volume adjacent to implants in diabetic rats was significantly greater than controls (P<0.05). Diabetic animals treated with insulin were not statistically different from controls. Conclusions: Induction of diabetes with STZ is associated with increased bone response compared with controls. This response was mediated by treatment with insulin.

KW - Animal study

KW - Dental implants

KW - Diabetes

KW - Insulin

KW - Rats

KW - Streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=33748361163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748361163&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0501.2006.01266.x

DO - 10.1111/j.1600-0501.2006.01266.x

M3 - Article

C2 - 16958687

AN - SCOPUS:33748361163

VL - 17

SP - 495

EP - 500

JO - Clinical Oral Implants Research

JF - Clinical Oral Implants Research

SN - 0905-7161

IS - 5

ER -